Healthcare -
Biotechnology - NASDAQ - US
$ 2.405
-2.63 %
$ 366 M
Market Cap
-26.72
P/E
HRTX - CHANGE IN WORKING CAPITAL
Change in Working Capital HRTX - Heron Therapeutics, Inc.
16.8 M
LAST VALUE
57.44%
2 YEAR CAGR
18.83%
5 YEAR CAGR
19.77%
10 YEAR CAGR